Petition Fund access to GLP-1 medications through the NHS for women with PCOS

Studies highlight the effectiveness of GLP-1 medications for women with PCOS. We think funding access to GLP-1 treatments, without restrictive BMI criteria or tier system barriers, would improve care and outcomes for these patients.

More details

Studies reveal that women with PCOS have higher absenteeism, increased unemployment, and a greater risk of disability retirement by age 52.

Without effective preventive treatments like GLP-1, we think there is a greater burden on the NHS due to downstream complications of untreated PCOS later on. This can include diabetes, cardiovascular disease, infertility, mental health issues, and cancer.

We think early intervention is essential to reduce these long-term healthcare costs on the NHS.

Sign this petition

14 signatures

Show on a map

10,000

At 10,000 signatures...

At 10,000 signatures, government will respond to this petition

At 100,000 signatures...

At 100,000 signatures, this petition will be considered for debate in Parliament

Share this petition